Início › Melanoma › Carolina do Norte
Ensaios clínicos de Melanoma em Carolina do Norte
31 estudos para Melanoma estão buscando participantes em locais em Carolina do Norte.
Cidades em Carolina do Norte
- Durham21 estudos
- Charlotte7 estudos
- Winston-Salem4 estudos
- Goldsboro4 estudos
- Wilson3 estudos
- Jacksonville3 estudos
- Asheville3 estudos
- Greenville3 estudos
Texto oficial do estudo (Inglês)
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
- Carolina Cancer Research Center, Wilson
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT06270706Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- AdventHealth Infusion Center Asheville, Asheville
- Southeastern Medical Oncology Center-Clinton, Clinton
- AdventHealth Infusion Center Haywood, Clyde
- e mais 6
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
Idades de 40 a 75 · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05334069NeoAdjuvant, Spare-Adjuvant (NASA) in Stage IIIB-IV (M1a) Melanoma
- Lineberger Comprehensive Cancer Center, Chapel Hill
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT07740941DESTINY-PANTUMOUR04
- Research Site, Durham
- Research Site, Wilson
RecrutandoEstudo observacional
Idades de 18 a 130 · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07124000BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
- Southeastern Medical Oncology Center-Clinton, Clinton
- Southeastern Medical Oncology Center-Goldsboro, Goldsboro
- Southeastern Medical Oncology Center-Jacksonville, Jacksonville
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT05136196A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
- Messino Cancer Center, Asheville
- Levine Cancer Institute, Charlotte
- Novant Health Cancer Institute, Charlotte
- e mais 3
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06246916Pan-tumor MRD Study
- Carolina Oncology Specialists, Charlotte
- Southeastern Medical Oncology Center (SMOC), Goldsboro
- Regional Medical Oncology Center, Wilson
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT06605404Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
- Duke Cancer Center Cary, Cary
- Duke University Medical Center, Durham
- Duke Cancer Center Raleigh, Raleigh
RecrutandoFase 3
Idades 75 e acima · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT07068074Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
- Carolina Biooncology Institute, Huntersville
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 18 de set. de 2026 · NCT05267626A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
- Local Institution - 0100, Durham
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 16 de set. de 2026 · NCT07492680A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- Wake Forest University at Clemmons, Clemmons
- Southeastern Medical Oncology Center-Clinton, Clinton
- Southeastern Medical Oncology Center-Goldsboro, Goldsboro
- e mais 4
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 15 de set. de 2026 · NCT04511013ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- UNC- Chapel Hill, Chapel Hill
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT05059444DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma
- University of North Carolina, Chapel Hill
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 9 de set. de 2026 · NCT07288112A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
- Duke Cancer Institute, Durham
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 2 de set. de 2026 · NCT07070232Project: Every Child for Younger Patients With Cancer
- Mission Hospital, Asheville
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
- Carolinas Medical Center/Levine Cancer Institute, Charlotte
- e mais 4
RecrutandoEstudo observacional
Até 25 anos · Todos os sexos · Atualizado em 25 de ago. de 2026 · NCT02402244Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
- Lineberger Comprehensive Cancer Center, Chapel Hill
RecrutandoFase 1
Idades de 18 a 99 · Todos os sexos · Atualizado em 19 de ago. de 2026 · NCT03454035A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
- Clinical Trial Site, Huntersville
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 6 de ago. de 2026 · NCT07749586A Feasibility Study Utilizing Immune Recall to Increase Response to Checkpoint Therapy
- Duke University Medical Center, Durham
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 8 de jul. de 2026 · NCT05077137Integrated Cancer Repository for Cancer Research
- Cape Fear Valley Health System, Fayetteville
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
Idades de 19 a 110 · Todos os sexos · Atualizado em 29 de jun. de 2026 · NCT02012699A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel
- UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill
RecrutandoFase 1/2
Idades de 18 a 70 · Todos os sexos · Atualizado em 15 de jun. de 2026 · NCT06940739Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
- Duke University Medical Center, Durham
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 8 de jun. de 2026 · NCT03947385IL-17 Blockade to Decrease irAEs (REPLAY)
- Duke University Health System, Durham
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 4 de jun. de 2026 · NCT07237594A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
- University of North Carolina at Chapel Hill, Chapel Hill
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 28 de abr. de 2026 · NCT06413680A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
- Duke University Medical Center, Durham
RecrutandoFase 2/3
Todas as idades · Todos os sexos · Atualizado em 2 de abr. de 2026 · NCT06581406Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Atrium Health Stanly/LCI-Albemarle, Albemarle
- Cone Health MedCenter Asheboro, Asheboro
- Cone Health Cancer Center at Alamance Regional, Burlington
- e mais 21
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 17 de mar. de 2026 · NCT06418204A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
- Carolina BioOncology Institute, Huntersville
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 21 de jan. de 2026 · NCT07317505Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
- Duke University Medical Center - Duke Cancer Center, Durham
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 17 de dez. de 2025 · NCT03567889SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Chapel Hill
- Massive Bio SYNERGY-AI site, Winston-Salem
RecrutandoEstudo observacional
Todas as idades · Todos os sexos · Atualizado em 28 de out. de 2025 · NCT03452774Excision of Lymph Node Trial (EXCILYNT) (Mel69)
- Duke University Health System, Durham
Recrutando
Idades 18 e acima · Todos os sexos · Atualizado em 17 de set. de 2025 · NCT05839912Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
- University of North Carolina at Chapel Hill, Chapel Hill
- Duke University Medical Center, Durham
- East Carolina University, Greenville
- e mais 1
Recrutando
Idades 18 e acima · Todos os sexos · Atualizado em 27 de nov. de 2024 · NCT03860883DermaSensor Postmarket Surveillance Study
- West Clinical Research, Morehead City
Recrutando
Idades 40 e acima · Todos os sexos · Atualizado em 31 de out. de 2024 · NCT06666790Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.